These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 26808367

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Acute lymphoblastic leukemia in children with Down syndrome: Comparative analysis versus patients without Down syndrome.
    Pennella CL, Rossi JG, Baialardo EM, Alonso CN, Guitter MR, Sánchez La Rosa CG, Millán NC, Alfaro EM, Zubizarreta PA, Felice MS.
    Arch Argent Pediatr; 2018 Aug 01; 116(4):e500-e507. PubMed ID: 30016023
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Acute leukaemia in children with Down syndrome: a population-based Nordic study.
    Zeller B, Gustafsson G, Forestier E, Abrahamsson J, Clausen N, Heldrup J, Hovi L, Jonmundsson G, Lie SO, Glomstein A, Hasle H, Nordic Society of Paediatric Haematology and Oncology (NOPHO).
    Br J Haematol; 2005 Mar 01; 128(6):797-804. PubMed ID: 15755283
    [Abstract] [Full Text] [Related]

  • 5. Acute lymphoblastic leukemia and Down syndrome: presenting features and treatment outcome in the experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP).
    Arico M, Ziino O, Valsecchi MG, Cazzaniga G, Baronci C, Messina C, Pession A, Santoro N, Basso G, Conter V, Italian Association of Pediatric Hematology and Oncology (AIEOP).
    Cancer; 2008 Aug 01; 113(3):515-21. PubMed ID: 18521927
    [Abstract] [Full Text] [Related]

  • 6. Child and adolescent Down syndrome-associated leukaemia: the Irish experience.
    O'Rafferty C, Kelly J, Storey L, Ryan C, O'Marcaigh A, Smith O.
    Ir J Med Sci; 2015 Dec 01; 184(4):877-82. PubMed ID: 25344131
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Epidemiology of Acute Leukemia among Children with Down Syndrome in Korea.
    Choi YB, Yoo KH.
    Cancer Res Treat; 2022 Apr 01; 54(2):572-578. PubMed ID: 34384014
    [Abstract] [Full Text] [Related]

  • 9. Long-term outcome for Down syndrome patients with hematopoietic disorders.
    Li MJ, Lee NC, Yang YL, Yen HJ, Chang HH, Chien YH, Lu MY, Jou ST, Lin KH, Hwu WL, Lin DT.
    J Formos Med Assoc; 2016 Feb 01; 115(2):94-9. PubMed ID: 26234152
    [Abstract] [Full Text] [Related]

  • 10. Neuropsychological late effects of treatment for acute leukemia in children with Down syndrome.
    Roncadin C, Hitzler J, Downie A, Montour-Proulx I, Alyman C, Cairney E, Spiegler BJ.
    Pediatr Blood Cancer; 2015 May 01; 62(5):854-8. PubMed ID: 25545182
    [Abstract] [Full Text] [Related]

  • 11. Characteristics and survival of children with acute leukemia with Down syndrome or other birth defects in New York State.
    Qiao B, Austin AA, Schymura MJ, Browne ML.
    Cancer Epidemiol; 2018 Dec 01; 57():68-73. PubMed ID: 30326394
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Treatment results in children with myeloid leukemia of Down syndrome in Saudi Arabia: A multicenter SAPHOS leukemia group study.
    Jastaniah W, Alsultan A, Al Daama S, Ballourah W, Bayoumy M, Al-Anzi F, Al Shareef O, Abrar MB, Al Sudairy R, Al Ghemlas I.
    Leuk Res; 2017 Jul 01; 58():48-54. PubMed ID: 28445808
    [Abstract] [Full Text] [Related]

  • 14. Periconceptional vitamin useand leukemia risk in children with Down syndrome: a Children's Oncology Group study.
    Ross JA, Blair CK, Olshan AF, Robison LL, Smith FO, Heerema NA, Roesler M.
    Cancer; 2005 Jul 15; 104(2):405-10. PubMed ID: 15952191
    [Abstract] [Full Text] [Related]

  • 15. Vitamin supplement use among children with Down's syndrome and risk of leukaemia: a Children's Oncology Group (COG) study.
    Blair CK, Roesler M, Xie Y, Gamis AS, Olshan AF, Heerema NA, Robison LL, Ross JA, Children's Oncology Group (COG).
    Paediatr Perinat Epidemiol; 2008 May 15; 22(3):288-95. PubMed ID: 18426524
    [Abstract] [Full Text] [Related]

  • 16. AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity.
    Creutzig U, Reinhardt D, Diekamp S, Dworzak M, Stary J, Zimmermann M.
    Leukemia; 2005 Aug 15; 19(8):1355-60. PubMed ID: 15920490
    [Abstract] [Full Text] [Related]

  • 17. Immune-related conditions and acute leukemia in children with Down syndrome: a Children's Oncology Group report.
    Linabery AM, Li W, Roesler MA, Spector LG, Gamis AS, Olshan AF, Heerema NA, Ross JA.
    Cancer Epidemiol Biomarkers Prev; 2015 Feb 15; 24(2):454-8. PubMed ID: 25499068
    [Abstract] [Full Text] [Related]

  • 18. Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study.
    Forestier E, Izraeli S, Beverloo B, Haas O, Pession A, Michalová K, Stark B, Harrison CJ, Teigler-Schlegel A, Johansson B.
    Blood; 2008 Feb 01; 111(3):1575-83. PubMed ID: 17971484
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of Chemotherapeutic Drugs in Pediatric Patients With Down Syndrome and Leukemia.
    Hefti E, Blanco JG.
    J Pediatr Hematol Oncol; 2016 May 01; 38(4):283-7. PubMed ID: 26907658
    [Abstract] [Full Text] [Related]

  • 20. Epidemiology of childhood leukemia in the presence and absence of Down syndrome.
    Mezei G, Sudan M, Izraeli S, Kheifets L.
    Cancer Epidemiol; 2014 Oct 01; 38(5):479-89. PubMed ID: 25113940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.